These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28707792)

  • 1. Editorial: migration studies to determine risk and cause of inflammatory bowel disease-authors' reply.
    Damas OM; Schwartz SJ; Abreu MT
    Aliment Pharmacol Ther; 2017 Aug; 46(4):467. PubMed ID: 28707792
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply.
    Fairbrass KM; Hamlin PJ; Gracie DJ; Ford AC
    Aliment Pharmacol Ther; 2022 Oct; 56(8):1302-1303. PubMed ID: 36168260
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease - authors' reply.
    Diederen K; Hoekman DR; Benninga MA
    Aliment Pharmacol Ther; 2016 Aug; 44(3):309-10. PubMed ID: 27375102
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: depression in the setting of inflammatory bowel disease means we have failed to provide early, effective, psychosocial care-authors' reply.
    Alexakis C; Kumar S; Saxena S; Hotopf M; Pollok R
    Aliment Pharmacol Ther; 2017 Sep; 46(5):554-555. PubMed ID: 28776734
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Authors' reply.
    Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
    Aliment Pharmacol Ther; 2017 Oct; 46(7):698-699. PubMed ID: 28880440
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: ONO-2952 in irritable bowel syndrome with diarrhoea - authors' reply.
    Whitehead WE; Duffy K; Sharpe J; Nabata T; Bruce M
    Aliment Pharmacol Ther; 2017 Apr; 45(7):1005. PubMed ID: 28256085
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: gut-directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome? Authors' reply.
    Peters SL; Yao CK; Philpott H; Yelland GW; Muir JG; Gibson PR
    Aliment Pharmacol Ther; 2016 Oct; 44(8):902-3. PubMed ID: 27634231
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome. Authors' reply.
    Xu XJ; Yao SK
    Aliment Pharmacol Ther; 2017 Feb; 45(4):568-569. PubMed ID: 28074518
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea-are we any closer? Authors' reply.
    Gunn D; Garsed K; Lam C; Singh G; Lingaya M; Wahl V; Niesler B; Henry A; Hall I; Whorwell P; Spiller R
    Aliment Pharmacol Ther; 2019 Oct; 50(7):826-827. PubMed ID: 31532555
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: serotonin and irritable bowel syndrome--reconciling pharmacological effects with basic biology; authors' reply.
    Mujagic Z; Keszthelyi D; Thijssen AY; Jonkers DM; Masclee AA
    Aliment Pharmacol Ther; 2016 Mar; 43(5):646-7. PubMed ID: 26843337
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: irritable bowel syndrome-in addition to having properly-trained dietitians, is it time to add a yoga teacher to our multidisciplinary team? Authors' reply.
    Schumann D; Cramer H
    Aliment Pharmacol Ther; 2018 Feb; 47(3):433-434. PubMed ID: 29314131
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: differentiating chronic idiopathic constipation from constipation-predominant irritable bowel syndrome--possible and important?--Authors' reply.
    Talley NJ; Koloski NA; Jones MP
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1300. PubMed ID: 25968151
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative Risk-Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    Bennett WE
    Drug Saf; 2016 Apr; 39(4):295-305. PubMed ID: 26467550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Qin X
    Inflamm Bowel Dis; 2017 Feb; 23(2):E11-E12. PubMed ID: 28079624
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: latent class analysis to improve confidence in the diagnosis of IBS - authors' reply.
    Sood R; Gracie DJ; Gold MJ; To N; Pinto-Sanchez MI; Bercik P; Moayyedi P; Ford AC; Law GR
    Aliment Pharmacol Ther; 2017 May; 45(9):1268-1269. PubMed ID: 28370047
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease-Authors' reply.
    Qiu XY; Lu MJ; Zhang HJ
    Aliment Pharmacol Ther; 2018 Mar; 47(5):690-691. PubMed ID: 29417626
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of symptoms, laboratory parameters and illness perception in patients with irritable bowel syndrome and inflammatory bowel disease].
    Bor R; Balanyi Z; Farkas K; Bálint A; Rutka M; Szűcs M; Milassin Á; Szepes Z; Nagy F; Molnár T
    Orv Hetil; 2015 Jun; 156(23):933-8. PubMed ID: 26027601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.
    Goodoory VC; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2022 Sep; 56(5):894-895. PubMed ID: 35934862
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: balancing fibre and FODMAPs in IBS - a 'rye' look at an old problem. Authors' reply.
    Laatikainen R; Loponen J; Korpela R
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1135. PubMed ID: 27734544
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Noncoeliac gluten sensitivity--a disease of the mind or gut? Authors' reply.
    Peters SL; Biesiekierski JR; Yelland GW; Muir JG; Gibson PR
    Aliment Pharmacol Ther; 2014 Jul; 40(1):114-5. PubMed ID: 24903429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.